Clinical Trial Update: An Investigational Scan (18F-DOPA PET/CT) for Improving the Clinical Management of Brain Tumors [Phase 2]

View source ↗

Summary

An ongoing Phase 2 clinical trial evaluating 18F-DOPA PET/CT to improve clinical management of brain tumors; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Neoplasms

Drugs mentioned

• 18F-DOPA (fluorodopa)

Snippet

Sponsor: Mayo Clinic | Conditions: Malignant Brain Neoplasm | Phase 2 | Status: NOT_YET_RECRUITING